Skip to content

Clinical trials

Phase 2 Hepatitis B trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B Phase: Phase 2 Clear all

129 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20014
20023
20034
20046
20058
20064
20075
20083
20093
20108
20111
20122
20132
20141
20156
20162
20174
20186
20197
20208
20218
20226
20231
20245
20255
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed79
Terminated20
Unknown status11
Recruiting6
Not yet recruiting6
Active, not recruiting4
Withdrawn3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline34
Arrowhead Pharmaceuticals6
Gilead Sciences6
National Institute of Allergy and Infectious Diseases (NIAID)6
Assembly Biosciences5
F-star Therapeutics, Inc.4
Brii Biosciences Limited3
Bukwang Pharmaceutical3
Sanofi Pasteur, a Sanofi Company3
AusperBio Therapeutics Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B129
Hepatitis B, Chronic38
Tetanus21
Diphtheria20
Haemophilus Infections17
Poliomyelitis16
Hepatitis14
Whooping Cough10
Carcinoma, Hepatocellular7
HIV Infections7

Trials

Showing 1 to 25 of 129. Each trial links to its page on Pharma Observatory.

29 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.